Cyclacel Pharmaceuticals CYCC

$ 0.32 -2.4%

Quarterly report 2024-Q3
added 11-12-2024

Cyclacel Pharmaceuticals Balance Sheet 2011-2024 | CYCC

Annual Balance Sheet Cyclacel Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-3.34 M	-18.2 M	-36.5 M	-32.3 M	-10.7 M	-17.5 M	-23.9 M	-16.5 M	-20.4 M	-24.2 M	-31.1 M	-16.4 M	-24.4 M
Long Term Debt	37 K	106 K	30 K	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	1.06 M	1.19 M	100 K	124 K	130 K	176 K	206 K	-	-	-
Total Current Liabilities	8.16 M	7.51 M	5.29 M	2.49 M	2.42 M	4.45 M	4.11 M	5.26 M	5.75 M	7.49 M	7.5 M	9.34 M	6.5 M
Total Liabilities	8.2 M	7.62 M	5.32 M	3.54 M	3.61 M	4.55 M	4.24 M	5.39 M	5.93 M	7.7 M	7.5 M	9.34 M	6.5 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-428 M	-406 M	-385 M	-366 M	-358 M	-350 M	-343 M	-335 M	-323 M	-309 M	-289 M	-270 M	-257 M
Total Assets	8.8 M	28 M	42.6 M	36.8 M	15.3 M	19.8 M	26 M	19.7 M	24.8 M	29.4 M	35.5 M	19.4 M	26 M
Cash and Cash Equivalents	3.38 M	18.3 M	36.6 M	33.4 M	11.9 M	17.5 M	23.9 M	16.5 M	20.4 M	24.2 M	31.1 M	16.4 M	24.4 M
Book Value	607 K	20.4 M	37.3 M	33.3 M	11.7 M	15.3 M	21.8 M	14.3 M	18.8 M	21.7 M	28 M	10 M	19.5 M
Total Shareholders Equity	607 K	15.9 M	37.3 M	33.3 M	11.7 M	15.3 M	21.8 M	14.3 M	18.8 M	21.7 M	28 M	10 M	19.5 M

All numbers in USD currency

Quarterly Balance Sheet Cyclacel Pharmaceuticals

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	5 K	21 K	37 K	66 K	80 K	106 K	107 K	113 K	15 K	30 K	44 K	-	996 K	1.06 M	1.06 M	1.06 M	1.06 M	1.19 M	1.19 M	1.19 M	1.19 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	6.35 M	7.19 M	8.37 M	8.2 M	6.81 M	7.42 M	7.5 M	4.46 M	5.14 M	6.22 M	5.32 M	3.64 M	3.12 M	3.77 M	3.54 M	3.54 M	3.54 M	3.54 M	3.61 M	3.61 M	3.61 M	3.61 M	4.55 M	4.55 M	4.55 M	4.55 M	4.24 M	4.24 M	4.24 M	4.24 M	5.39 M	5.39 M	5.39 M	5.39 M	5.93 M	5.93 M	5.93 M	5.93 M	7.7 M	7.7 M	7.7 M	7.7 M	7.5 M	7.5 M	7.5 M	7.5 M	9.34 M	9.34 M	9.34 M	9.34 M	6.5 M	6.5 M	6.5 M	6.5 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-436 M	-434 M	-431 M	-428 M	-417 M	-412 M	-406 M	-399 M	-394 M	-389 M	-385 M	-380 M	-375 M	-370 M	-366 M	-366 M	-366 M	-366 M	-358 M	-358 M	-358 M	-358 M	-350 M	-350 M	-350 M	-350 M	-343 M	-343 M	-343 M	-343 M	-335 M	-335 M	-335 M	-335 M	-323 M	-323 M	-323 M	-323 M	-309 M	-309 M	-309 M	-309 M	-289 M	-289 M	-289 M	-289 M	-270 M	-270 M	-270 M	-270 M	-257 M	-257 M	-257 M	-257 M
Total Assets	5.38 M	8.19 M	6.16 M	8.8 M	16.4 M	22.1 M	27.5 M	31 M	35.3 M	39.6 M	42.6 M	45 M	46.3 M	51.8 M	36.8 M	36.8 M	36.8 M	36.8 M	15.3 M	15.3 M	15.3 M	15.3 M	19.8 M	19.8 M	19.8 M	19.8 M	26 M	26 M	26 M	26 M	19.7 M	19.7 M	19.7 M	19.7 M	24.8 M	24.8 M	24.8 M	24.8 M	29.4 M	29.4 M	29.4 M	29.4 M	35.5 M	35.5 M	35.5 M	35.5 M	19.4 M	19.4 M	19.4 M	19.4 M	26 M	26 M	26 M	26 M
Cash and Cash Equivalents	2.98 M	6 M	2.8 M	3.38 M	10.2 M	11.4 M	18.3 M	23.7 M	29.1 M	29.6 M	36.6 M	40.2 M	43.6 M	47.8 M	33.4 M	33.4 M	33.4 M	33.4 M	11.9 M	11.9 M	11.9 M	11.9 M	17.5 M	17.5 M	17.5 M	17.5 M	23.9 M	23.9 M	23.9 M	23.9 M	16.5 M	16.5 M	16.5 M	16.5 M	20.4 M	20.4 M	20.4 M	20.4 M	24.2 M	24.2 M	24.2 M	24.2 M	31.1 M	31.1 M	31.1 M	31.1 M	16.4 M	16.4 M	16.4 M	16.4 M	24.4 M	24.4 M	24.4 M	24.4 M
Book Value	-970 K	999 K	-2.21 M	607 K	9.63 M	14.6 M	20 M	26.6 M	30.2 M	33.4 M	37.3 M	41.4 M	43.2 M	48 M	33.3 M	33.3 M	33.3 M	33.3 M	11.7 M	11.7 M	11.7 M	11.7 M	15.3 M	15.3 M	15.3 M	15.3 M	21.8 M	21.8 M	21.8 M	21.8 M	14.3 M	14.3 M	14.3 M	14.3 M	18.8 M	18.8 M	18.8 M	18.8 M	21.7 M	21.7 M	21.7 M	21.7 M	28 M	28 M	28 M	28 M	10 M	10 M	10 M	10 M	19.5 M	19.5 M	19.5 M	19.5 M
Total Shareholders Equity	-970 K	999 K	-2.21 M	607 K	5.14 M	10.1 M	15.5 M	22.1 M	30.2 M	33.4 M	37.3 M	41.4 M	43.2 M	48 M	33.3 M	33.3 M	33.3 M	33.3 M	11.7 M	11.7 M	11.7 M	11.7 M	15.3 M	15.3 M	15.3 M	15.3 M	21.8 M	21.8 M	21.8 M	21.8 M	14.3 M	14.3 M	14.3 M	14.3 M	18.8 M	18.8 M	18.8 M	18.8 M	21.7 M	21.7 M	21.7 M	21.7 M	28 M	28 M	28 M	28 M	10 M	10 M	10 M	10 M	19.5 M	19.5 M	19.5 M	19.5 M

All numbers in USD currency